HomeInsightsPE

MPS Pharmaa Ltd P/E Ratio

MPS Pharmaa Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

2.5 K

stocks traded

Last Updated time: 23 Jul 14:00 PM

Image

MPS Pharmaa Ltd

NSE: ADVIKLABS

PE

0

Last updated : 23 Jul 14:00 PM

Key Highlights

    The P/E Ratio of MPS Pharmaa Ltd is 0 as of 23 Jul 14:00 PM .a1#The P/E Ratio of MPS Pharmaa Ltd changed from 0 on March 2019 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#The Latest Trading Price of MPS Pharmaa Ltd is ₹ 3.66 as of 22 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.6 in 5 years. This represents a CAGR of -0.64%a1# The PE Ratio of Automobile industry is 18.9. The PE Ratio of Finance industry is 23.5. The PE Ratio of IT - Software industry is 29.4. The PE Ratio of Pharmaceuticals industry is 38.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.5. In 2024a1#The Market Cap of MPS Pharmaa Ltd changed from ₹ 3.63 crore on March 2019 to ₹ 4.01 crore on March 2023 . This represents a CAGR of 2.01% over 5 years. a1#The Revenue of MPS Pharmaa Ltd changed from ₹ 0.02 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% a1#The EBITDA of MPS Pharmaa Ltd changed from ₹ -0.17 crore to ₹ -0.21 crore over 8 quarters. This represents a CAGR of 11.14% a1#The Net Pr of MPS Pharmaa Ltd changed from ₹ -0.2 crore to ₹ -0.24 crore over 8 quarters. This represents a CAGR of 9.54% a1#The Dividend Payout of MPS Pharmaa Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of MPS Pharmaa Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of MPS Pharmaa Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

Company Fundamentals for MPS Pharmaa Ltd

Market Cap

6 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

3.5

Day’s High

3.66

Day’s Low

3.66

DTE *

3.7

ROE *

-42.2

52 Week High

3.66

52 Week Low

2.42

ROCE *

-9.2

* All values are consolidated

Last Updated time: 23 Jul 14:00 PM

* All values are consolidated

Last Updated time: 23 Jul 14:00 PM

Image

MPS Pharmaa Ltd

NSE: ADVIKLABS

PRICE

3.66

0.00 (0.00%)

stock direction

Last updated : 22 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

Asset Value vs Market Value of MPS Pharmaa Ltd

Market Value

7

Asset Value

3

1.8 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
MPS Pharmaa Ltd06
Sun Pharmaceuticals Industries Ltd38380,990
Divis Laboratories Ltd75120,383
Cipla Ltd28120,296
Zydus Lifesciences Ltd30116,160
Dr Reddys Laboratories Ltd20112,931

Key Valuation Metric of MPS Pharmaa Ltd

Earnings

-0 Cr

0.0 X

PE Ratio

Market Cap

₹6.99Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-0 Cr

0.0 X

PE Ratio

Market Cap

₹6.99Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of MPS Pharmaa Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of MPS Pharmaa Ltd

Period
Mar '194
Mar '201
Mar '211
Mar '223
Mar '234

* All values are a in crore

×

Historical Revenue of MPS Pharmaa Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of MPS Pharmaa Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical EBITDA of MPS Pharmaa Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of MPS Pharmaa Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Net Profit of MPS Pharmaa Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of MPS Pharmaa Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Dividend Payout of MPS Pharmaa Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of MPS Pharmaa Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About MPS Pharmaa Ltd

About MPS Pharmaa Ltd

    MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, it is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level. In 2021-22, the Company became an Associate Company of Vikas Lifecare Limited as it had acquired 22.04% of the shareholding of the Company. As a result, on 20-06-2022, Vikas Lifecare Limited divested 04.53% shareholding of the Company; thereby its aggregate shareholding into the Company decreased to 17.51% and hence, the Company ceased to be an Associate of Vikas Lifecare Limited.

MPS Pharmaa Ltd News Hub

News

MPS Pharmaa to convene board meeting

MPS Pharmaa will hold a meeting of the Board of Directors of the Company on 30 May 2024 Po...

Read more

15 May 202411:48

News

MPS Pharmaa to convene board meeting

MPS Pharmaa will hold a meeting of the Board of Directors of the Company on 26 March 2024....

Read more

15 Mar 202410:10

News

MPS Pharmaa to hold board meeting

MPS Pharmaa will hold a meeting of the Board of Directors of the Company on 13 February 20...

Read more

03 Feb 202411:20

News

MPS Pharmaa to declare Quarterly Result

MPS Pharmaa will hold a meeting of the Board of Directors of the Company on 9 November 202...

Read more

01 Nov 202315:58

News

MPS Pharmaa AGM scheduled

MPS Pharmaa announced that the 29th Annual General Meeting (AGM) of the company will be he...

Read more

02 Sep 202312:55

News

MPS Pharmaa to convene board meeting

MPS Pharmaa will hold a meeting of the Board of Directors of the Company on 29 August 2023...

Read more

24 Aug 202316:26

Product Composition by Percentage (Revenue)

FAQs for PE of MPS Pharmaa Ltd

What is MPS Pharmaa Ltd current share price?

The current market price of MPS Pharmaa Ltd as of July 23, 2024 is ₹3.66.

What is MPS Pharmaa Ltd's market cap?

MPS Pharmaa Ltd's market capitalisation stood at ₹6 Cr as of July 23, 2024

What are MPS Pharmaa Ltd's total net assets?

According to MPS Pharmaa Ltd's most recent financial filings, the company's net assets total ₹2.5 Cr.

Is MPS Pharmaa Ltd making a profit or loss?

MPS Pharmaa Ltd's net Profit as of July 23, 2024 is close to ₹0 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199